Ticker LaunchCanada to US · Cross-listing · MSLE
Satellos Bioscience Inc.
Satellos Bioscience Inc. (MSLE), a Canada-based company, cross-listed on Nasdaq on Feb 5, 2026, registering its securities on Form 8-A12B.
- Type
- Cross-listing
- US exchange
- Nasdaq
- Ticker
- MSLE
- Listed
- Feb 5, 2026
- Province
- Canada
- Registration form
- 8-A12B
- Security
- Common shares
- Sector
- Biotech & pharma
More on this listing for subscribers
- Analyst notes from the filings
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Registration (8-A12B) Feb 5, 2026
- Offering document
- All filings on EDGAR CIK 1421642
Other Canadian companies listing in the US
- Versamet Royalties CorporationNasdaq · Mar 2, 2026
- Highlander Silver Corp.NYSE American · Feb 27, 2026
- Quantum eMotion Corp.NYSE American · Jan 22, 2026
- Mayfair Gold Corp.NYSE American · Jan 20, 2026
- Blue Moon Metals Inc.Nasdaq · Jan 16, 2026
- Santacruz Silver Mining Ltd.Nasdaq · Jan 12, 2026